APVOVSBIAF• 28 Days (Normalized)
APVO vs BIAF (Aptevo Therapeutics Inc. vs bioAffinity Technologies Inc.)
Showing Closing Date Range from Aug, 17 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
APVO Performance $1.87
-33.45%
Aptevo Therapeutics Inc.
Normalized Baseline0.00%
BIAF Performance $8.03
+36.48%
bioAffinity Technologies Inc.
Normalized Baseline0.00%
Alpha Spread Margin BIAF LEADS
-69.93%
BIAF outperforming by 69.93%
APVOBIAF
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
APVO BIAF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | APVO Price | APVO Gain (%) | BIAF Price | BIAF Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $1.87 | -33.45% | $8.03 | +36.48% | -69.93% |
| Sep 11, 2026 | $1.82 | -35.23% | $7.95 | +35.20% | -70.43% |
| Sep 10, 2026 | $1.83 | -34.88% | $9.39 | +59.69% | -94.57% |
| Sep 09, 2026 | $1.85 | -34.34% | $10.50 | +78.57% | -112.91% |
| Sep 08, 2026 | $1.88 | -33.10% | $8.93 | +51.87% | -84.97% |
| Sep 04, 2026 | $1.74 | -38.08% | $15.27 | +159.69% | -197.77% |
| Sep 03, 2026 | $1.71 | -39.15% | $12.78 | +117.35% | -156.50% |
| Sep 02, 2026 | $2.60 | -7.47% | $9.75 | +65.82% | -73.29% |
| Sep 01, 2026 | $2.34 | -16.73% | $6.59 | +12.07% | -28.80% |
| Aug 31, 2026 | $2.44 | -13.17% | $4.56 | -22.45% | +9.28% |
| Aug 28, 2026 | $2.37 | -15.84% | $4.87 | -17.18% | +1.34% |
| Aug 27, 2026 | $2.42 | -13.88% | $5.06 | -13.95% | +0.07% |
| Aug 26, 2026 | $2.41 | -14.23% | $5.09 | -13.44% | -0.79% |
| Aug 25, 2026 | $2.46 | -12.46% | $5.19 | -11.73% | -0.73% |
| Aug 24, 2026 | $2.41 | -14.23% | $5.82 | -1.02% | -13.21% |
Page 1 of 2